<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments for </title>
	<atom:link href="http://medicareinsights.com/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://medicareinsights.com</link>
	<description></description>
	<lastBuildDate>Fri, 01 Mar 2013 03:49:25 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2</generator>
	<item>
		<title>Comment on The “Patent Cliff” and its Effects upon Workers’ Compensation Claims by Jake</title>
		<link>http://medicareinsights.com/2013/02/26/the-%e2%80%9cpatent-cliff%e2%80%9d-and-its-effects-upon-workers%e2%80%99-compensation-claims/#comment-53</link>
		<dc:creator>Jake</dc:creator>
		<pubDate>Fri, 01 Mar 2013 03:49:25 +0000</pubDate>
		<guid isPermaLink="false">http://medicareinsights.com/?p=2010#comment-53</guid>
		<description>The price of Lexapro has not dropped much as a generic. Not enough companies are getting on board to make it to produce real competition in prices - in particular, I don&#039;t think Ranbaxy is interested.</description>
		<content:encoded><![CDATA[<p>The price of Lexapro has not dropped much as a generic. Not enough companies are getting on board to make it to produce real competition in prices &#8211; in particular, I don&#8217;t think Ranbaxy is interested.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on MSP Mid 2012 Legal Updates Webinar by Settlement Solutions</title>
		<link>http://medicareinsights.com/2012/08/20/msp-mid-2012-legal-updates-webinar/#comment-51</link>
		<dc:creator>Settlement Solutions</dc:creator>
		<pubDate>Wed, 05 Sep 2012 15:28:33 +0000</pubDate>
		<guid isPermaLink="false">http://medicareinsights.com/?p=1734#comment-51</guid>
		<description>Mary,

Thank you for your question. Claims with Medicare beneficiaries need to be reported, regardless of where the beneficiary currently is domiciled. It would not be the country that needs to report the claim, but rather the RRE. The RRE would submit the information through CMS&#039; secure data portal. Although we are unfamiliar with the privacy laws in other countries, the data submitted to CMS would be secure and would only be used for internal purposes at CMS for coordination of Medicare benefits. We hope that you are able to join our webinar on September 25th and please feel free to reach out with any questions in the future.</description>
		<content:encoded><![CDATA[<p>Mary,</p>
<p>Thank you for your question. Claims with Medicare beneficiaries need to be reported, regardless of where the beneficiary currently is domiciled. It would not be the country that needs to report the claim, but rather the RRE. The RRE would submit the information through CMS&#8217; secure data portal. Although we are unfamiliar with the privacy laws in other countries, the data submitted to CMS would be secure and would only be used for internal purposes at CMS for coordination of Medicare benefits. We hope that you are able to join our webinar on September 25th and please feel free to reach out with any questions in the future.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on MSP Mid 2012 Legal Updates Webinar by Mary Ellen McClain</title>
		<link>http://medicareinsights.com/2012/08/20/msp-mid-2012-legal-updates-webinar/#comment-50</link>
		<dc:creator>Mary Ellen McClain</dc:creator>
		<pubDate>Fri, 31 Aug 2012 12:26:28 +0000</pubDate>
		<guid isPermaLink="false">http://medicareinsights.com/?p=1734#comment-50</guid>
		<description>Has our gov&#039;t given any consideration on how they plan to deal with requiring foreign countries (UK &amp; Canada particularly) to rsvp with info on medicare related claims, as there are very stringent laws in these countries which prohibit revealing much of the information that medicare request ?</description>
		<content:encoded><![CDATA[<p>Has our gov&#8217;t given any consideration on how they plan to deal with requiring foreign countries (UK &amp; Canada particularly) to rsvp with info on medicare related claims, as there are very stringent laws in these countries which prohibit revealing much of the information that medicare request ?</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on CMS Issues ANPRM Regarding MSP and Future Medicals by Settlement Solutions</title>
		<link>http://medicareinsights.com/2012/06/20/cms-issues-anprm-regarding-msp-and-future-medicals/#comment-47</link>
		<dc:creator>Settlement Solutions</dc:creator>
		<pubDate>Thu, 28 Jun 2012 17:05:31 +0000</pubDate>
		<guid isPermaLink="false">http://medicareinsights.com/?p=1639#comment-47</guid>
		<description>We appreciate your feedback Peter.  Selecting a dollar threshold may be difficult to apply across all claims due to things such as comparative negligence, policy limits, and if the settlement is primarily addressing special damages, general damages, future needs or all three.  These issues, other issues, and the points you made in your comment highlight the need for all stakeholders to provide input on the ANPRM. Hopefully, once all of these issues are raised, CMS will be in a better position to create a process that both protects its interests and is reasonable, clear and straight forward.</description>
		<content:encoded><![CDATA[<p>We appreciate your feedback Peter.  Selecting a dollar threshold may be difficult to apply across all claims due to things such as comparative negligence, policy limits, and if the settlement is primarily addressing special damages, general damages, future needs or all three.  These issues, other issues, and the points you made in your comment highlight the need for all stakeholders to provide input on the ANPRM. Hopefully, once all of these issues are raised, CMS will be in a better position to create a process that both protects its interests and is reasonable, clear and straight forward.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on CMS Issues ANPRM Regarding MSP and Future Medicals by Peter Gelsinger</title>
		<link>http://medicareinsights.com/2012/06/20/cms-issues-anprm-regarding-msp-and-future-medicals/#comment-46</link>
		<dc:creator>Peter Gelsinger</dc:creator>
		<pubDate>Wed, 20 Jun 2012 15:11:27 +0000</pubDate>
		<guid isPermaLink="false">http://medicareinsights.com/?p=1639#comment-46</guid>
		<description>This has become so cumbersome for insurers to do on every single liability claim, regardless of whether there is any Medicare/Medicaid involved.  I believe option #2 is the most viable for both CMS and the insurance companies with CMS not pursuing any reimbursement on claims below $100,000 where there is no WC or No-Fault claims.  Under $100,000 you are usually dealing with minimal type injuries that will not have residual treatment and thus would not impact Medicare in the future.  It would eliminate about 80% to 90% of the liability claims on the books from the process and would allow settlements to move much more quickly for claims &lt;=$100,000.</description>
		<content:encoded><![CDATA[<p>This has become so cumbersome for insurers to do on every single liability claim, regardless of whether there is any Medicare/Medicaid involved.  I believe option #2 is the most viable for both CMS and the insurance companies with CMS not pursuing any reimbursement on claims below $100,000 where there is no WC or No-Fault claims.  Under $100,000 you are usually dealing with minimal type injuries that will not have residual treatment and thus would not impact Medicare in the future.  It would eliminate about 80% to 90% of the liability claims on the books from the process and would allow settlements to move much more quickly for claims &lt;=$100,000.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
